Prophylactic use of granulocyte colony-stimulating factor after induction chemotherapy in patients with newly diagnosed acute myeloid leukemia may increase the complete remission rate: a meta-analysis of five randomised controlled trials.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples